We're Keeping An Eye On Bonus BioGroup's (TLV:BONS) Cash Burn Rate
Jun 14
Israeli (TA) Biotech Industry Analysis
UpdatedSep 26, 2023
DataAggregated Company Financials
Companies15
- 7D1.0%
- 3M3.3%
- 1Y6.2%
- YTD30.5%
The Biotech industry is up 3.1% in the last week, with BioLineRx up 19%. In the same time, Evogene was down 6.1%. This takes the industry's 12 month performance to a gain of 6.2%. As for the next few years, earnings are expected to grow by 47% per annum.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 26 Sep 2023 | ₪2.3b | ₪619.1m | -₪379,560,038.00 | 73.6x | -6.1x | 3.7x |
| Thu, 24 Aug 2023 | ₪1.9b | ₪609.8m | -₪336,786,986.00 | 65.1x | -5.6x | 3.1x |
| Sat, 22 Jul 2023 | ₪1.9b | ₪539.1m | -₪390,545,047.00 | n/a | -4.9x | 3.6x |
| Mon, 19 Jun 2023 | ₪1.9b | ₪528.8m | -₪384,987,110.00 | n/a | -4.9x | 3.6x |
| Wed, 17 May 2023 | ₪1.7b | ₪530.9m | -₪367,043,272.00 | n/a | -4.7x | 3.3x |
| Fri, 14 Apr 2023 | ₪1.6b | ₪614.4m | -₪426,739,762.00 | 2.4x | -3.8x | 2.6x |
| Sun, 12 Mar 2023 | ₪1.6b | ₪557.5m | -₪461,079,216.00 | 4.7x | -3.4x | 2.8x |
| Tue, 07 Feb 2023 | ₪1.6b | ₪540.4m | -₪466,473,612.00 | 4.7x | -3.5x | 3x |
| Thu, 05 Jan 2023 | ₪1.6b | ₪535.0m | -₪475,995,177.00 | 15.8x | -3.4x | 3x |
| Sat, 03 Dec 2022 | ₪1.7b | ₪474.6m | -₪461,745,307.00 | 18.3x | -3.7x | 3.6x |
| Mon, 31 Oct 2022 | ₪1.9b | ₪493.8m | -₪487,440,189.00 | 16.9x | -3.8x | 3.8x |
| Wed, 28 Sep 2022 | ₪1.9b | ₪492.3m | -₪486,338,129.00 | 18.5x | -3.9x | 3.9x |
| Fri, 26 Aug 2022 | ₪2.2b | ₪447.9m | -₪402,124,595.00 | 5.8x | -5.4x | 4.9x |
| Sun, 24 Jul 2022 | ₪2.1b | ₪491.8m | -₪399,827,322.00 | 13.5x | -5.2x | 4.2x |
| Tue, 21 Jun 2022 | ₪2.2b | ₪487.8m | -₪400,201,775.00 | 12.4x | -5.5x | 4.5x |
| Thu, 19 May 2022 | ₪2.4b | ₪474.8m | -₪487,770,571.00 | 13.8x | -4.9x | 5.1x |
| Sat, 16 Apr 2022 | ₪2.9b | ₪458.8m | -₪491,828,710.00 | 10x | -5.8x | 6.2x |
| Mon, 14 Mar 2022 | ₪2.7b | ₪462.5m | -₪221,835,867.00 | 7x | -12.4x | 5.9x |
| Wed, 09 Feb 2022 | ₪2.9b | ₪458.9m | -₪221,715,542.00 | 7.1x | -13.3x | 6.4x |
| Fri, 07 Jan 2022 | ₪3.7b | ₪447.9m | -₪214,106,337.00 | 10.3x | -17.1x | 8.2x |
| Sun, 05 Dec 2021 | ₪3.7b | ₪426.4m | -₪218,627,772.00 | 9.3x | -16.8x | 8.6x |
| Tue, 02 Nov 2021 | ₪4.1b | ₪462.4m | -₪167,370,876.00 | 10x | -24.3x | 8.8x |
| Thu, 30 Sep 2021 | ₪4.1b | ₪474.5m | -₪173,585,294.00 | 10.3x | -23.4x | 8.6x |
| Sat, 28 Aug 2021 | ₪4.2b | ₪483.2m | -₪167,305,098.00 | 4x | -24.9x | 8.6x |
| Sun, 04 Jul 2021 | ₪3.9b | ₪483.2m | -₪167,305,098.00 | 5.5x | -23.6x | 8.2x |
| Wed, 07 Apr 2021 | ₪4.2b | ₪528.7m | -₪109,530,611.00 | 3x | -38x | 7.9x |
| Sat, 09 Jan 2021 | ₪2.9b | ₪520.8m | -₪57,738,930.40 | 2.9x | -50.8x | 5.6x |
| Fri, 02 Oct 2020 | ₪2.9b | ₪546.7m | -₪199,116,926.70 | 9.9x | -14.7x | 5.4x |
Price to Earnings Ratio
-14.7x
Current Industry PE
- Investors are pessimistic on the Israeli Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.6x is higher than the industry's current PS ratio of 3.7x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 4.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Israeli Biotech compare with similar industries?
| IL Market | 1.34% | |
| Healthcare | -0.18% | |
| Biotech | 0.95% | |
| Biotech | 0.95% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BLRX BioLineRx | ₪0.52 | 3.2% +₪14.8m | 124.0% | PB6x | |
| GFC-M G.F.C Green Fields Capital | ₪9.71 | 6.8% +₪6.3m | n/a | PE59.7x | |
| PLNT PlantArc Bio | ₪4.87 | 4.2% +₪642.0k | -32.9% | PS7.3x | |
| XTLB XTL Biopharmaceuticals | ₪0.036 | 2.9% +₪544.9k | -23.4% | PB1.9x | |
| HDST-M HBL - Hadasit Bio-Holdings | ₪0.74 | 5.7% +₪443.5k | -72.9% | PB0.7x |